Sirna Therapeutics Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sirna Therapeutics Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: foxtrot who wrote (271)	11/16/1999 12:53:00 PM
From: Biomaven	Read Replies (1) of 562

Well I'm not sure if this was the "big news" but this was released today: New Cancer Drug in Multi-Dose Safety and Efficacy Studies; Patients Treated with Angiozyme in Phase I/II Studies at the Cleveland Clinic BOULDER, Colo. and EMERYVILLE, Calif., Nov. 16 /PRNewswire/ -- Ribozyme Pharmaceuticals Inc. (Nasdaq: RZYM - news) and Chiron Corporation (Nasdaq: CHIR - news) announced today the initiation of dosing of patients with Angiozyme(TM) in a multi-dose Phase I/II clinical trial at the Cleveland Clinic. Angiozyme, an anti-angiogenic ribozyme, has already demonstrated safety and tolerability in single dose Phase Ia studies in normal volunteers and Phase Ib studies in cancer patients. It is the first chemically synthesized ribozyme to have reached this stage of development. <snip> If all we are talking about here was the commencement of Phase II, without any efficacy results from Phase I, then I think the announcement yesterday was extreme hype. I took a flyer and shorted a few shares at $16 today. I could still regret it of course if the announcement tomorrow has any substance. The company has interesting technology, but it is still very early, and the price pop today I felt was extreme. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next